BMY stock: buy or sell?

BMY stock price: $65.63 0.71% At close on February 21st, 2020

Updated on:
February 21st, 2020


Shares of Bristol-Myers Squibb ended today at $65.63 and stepped up a tiny 0.71%.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide.

Should I buy BMY stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading plan that matches with your character as inversor. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Bristol-Myers Squibb stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean BMY will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Bristol-Myers Squibb stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for BMY stock for the last 30 days.

BMY stock analysis

Daily outlook

Bristol-Myers Squibb shares stepped up 0.71% to $65.63 today.

Shares of Bristol-Myers Squibb closed today at $65.63 and stepped up a tiny 0.71%. Since SMA100d and SMA200d crossed up on October, BMY price climbed $11.59 per share (21.45%).

BMY stock chart (daily)

Weekly outlook

Bristol-Myers Squibb shares depreciated -1.13% this week, ending at $65.63.

Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $68.34 resistance. Since late October 2019 when SMA20w and SMA40w crossed up, BMY price gained $12.97 per share (24.63%). Since price and SMA40w lines crossed up late August 2019, BMY climbed $19.76 (43.08%).

BMY stock chart (weekly)

BMY stock price history

BMY stock historical price chart

BMY stock reached 52-week highs on January/22 at $68.34, and all-time highs 2016-07-15 with a price of 69.7.

BMY stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' BMY stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price target for Bristol-Myers Squibb stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since April, when Bristol-Myers Squibb presented its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
BMY earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual revenues report draw a remarkable gain of 8.59% to $22,561.00 M USD. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) skyrocketed a 16.96% to 21.81%.

Bristol-Myers Squibb fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Bristol-Myers Squibb TTM sales up to March 2019 were $23,288.00 and earnings $5,144.00 M dollars. When comparing this TTM figures with the last reported annuality, we can review Bristol-Myers Squibb business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, appreciated a beatiful 3.22%. Regarding profit margin, Bristol-Myers Squibb remained steady 0.28% to 21.81%

BMY annual Sales and Income evolution
2013$16,390 M-$2,560 M15.6%-
2014$15,879 M-3.12%$2,004 M12.6%-21.72%
2015$16,560 M4.29%$1,565 M9.5%-21.91%
2016$19,427 M17.31%$4,457 M22.9%184.79%
2017$20,776 M6.94%$1,007 M4.8%-77.41%
2018$22,561 M8.59%$4,920 M21.8%388.58%
TTM $23,288 M3.22%$5,144 M22.1%4.55%

Quarterly financial results

Bristol-Myers Squibb posted $5,920.00 million in revenues for 2019-Q1, a -0.89% decline compared to previous quarter. Reported quarter income marked $1,710.00 million with a profit margin of 28.89%. Profit margin soared a 9.46% compared to previous quarter when profit margin was 19.42%. When comparing sales to same quarter last year, Bristol-Myers Squibb sales marked an amazing growth and rocketed a 14.00%.
BMY quarterly Sales and Income evolution
2017-Q2$5,140 M-$916 M17.8%-
2017-Q3$5,250 M2.14%$845 M16.1%-7.75%
2017-Q4$5,449 M3.79%$-2,328 M-42.7%-375.50%
2018-Q1$5,193 M-4.70%$1,486 M28.6%-163.83%
2018-Q2$5,704 M9.84%$373 M6.5%-74.90%
2018-Q3$5,691 M-0.23%$1,901 M33.4%409.65%
2018-Q4$5,973 M4.96%$1,160 M19.4%-38.98%
2019-Q1$5,920 M-0.89%$1,710 M28.9%47.41%

Bristol-Myers Squibb ownership

When you are planning to buy shares of a company, it's always worth to overview its ownership structure.

Bristol-Myers Squibb shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.10% of all shares.

In case of Bristol-Myers Squibb stock, 62.07% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for BMY stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Bristol-Myers Squibb:

Market cap$107.0 B
Total shares1,630.0 M
Float shares1,630.0 M
  - Institutional holdings (%)62.1%
  - Insider holdings (%)0.1%
Shares in short selling0.0%

BMY summary

Friday, February 21st, 2020
Day range$64.80 - $65.87
Previous close$65.17
Session gain0.71%
Average true range$1.20
50d mov avg$64.67
100d mov avg$59.77
200d mov avg$52.88
Daily pattern
Weekly pattern lb02a

Bristol-Myers Squibb performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Bristol-Myers Squibb to :
BMYBristol-Myers Squ...17.09%43.08%33.07%

Bristol-Myers Squibb competitors

Unfortunately, we could not find any public company that could be defined as Bristol-Myers Squibb competitor. This doesn't mean Bristol-Myers Squibb does not have any competitor in the market, it's just we could not detected it.

    Latest BMY stock news